Medtronic Operating Expenses 2010-2025 | MDT
Medtronic annual/quarterly operating expenses history and growth rate from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Medtronic operating expenses for the quarter ending April 30, 2025 were $7.490B, a 0.61% decline year-over-year.
- Medtronic operating expenses for the twelve months ending April 30, 2025 were $27.581B, a 1.33% increase year-over-year.
- Medtronic annual operating expenses for 2025 were $27.581B, a 1.33% increase from 2024.
- Medtronic annual operating expenses for 2024 were $27.219B, a 5.74% increase from 2023.
- Medtronic annual operating expenses for 2023 were $25.742B, a 0.74% decline from 2022.
| Medtronic Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2025 | $27,581 |
| 2024 | $27,219 |
| 2023 | $25,742 |
| 2022 | $25,933 |
| 2021 | $25,633 |
| 2020 | $24,122 |
| 2019 | $24,289 |
| 2018 | $23,313 |
| 2017 | $24,327 |
| 2016 | $23,472 |
| 2015 | $16,495 |
| 2014 | $13,192 |
| 2013 | $11,835 |
| 2012 | $11,436 |
| 2011 | $11,211 |
| 2010 | $10,678 |
| 2009 | $10,766 |
| Medtronic Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2025-04-30 | $7,490 |
| 2025-01-31 | $6,647 |
| 2024-10-31 | $6,809 |
| 2024-07-31 | $6,635 |
| 2024-04-30 | $7,536 |
| 2024-01-31 | $6,606 |
| 2023-10-31 | $6,644 |
| 2023-07-31 | $6,433 |
| 2023-04-30 | $6,977 |
| 2023-01-31 | $6,336 |
| 2022-10-31 | $6,182 |
| 2022-07-31 | $6,247 |
| 2022-04-30 | $6,417 |
| 2022-01-31 | $6,104 |
| 2021-10-31 | $6,284 |
| 2021-07-31 | $7,128 |
| 2021-04-30 | $6,584 |
| 2021-01-31 | $6,498 |
| 2020-10-31 | $6,717 |
| 2020-07-31 | $5,834 |
| 2020-04-30 | $5,681 |
| 2020-01-31 | $6,078 |
| 2019-10-31 | $6,355 |
| 2019-07-31 | $6,008 |
| 2019-04-30 | $6,200 |
| 2019-01-31 | $6,004 |
| 2018-10-31 | $5,937 |
| 2018-07-31 | $6,148 |
| 2018-04-30 | $6,216 |
| 2018-01-31 | $5,933 |
| 2017-10-31 | $5,156 |
| 2017-07-31 | $6,008 |
| 2017-04-30 | $6,232 |
| 2017-01-31 | $6,136 |
| 2016-10-31 | $5,960 |
| 2016-07-31 | $5,999 |
| 2016-04-30 | $5,992 |
| 2016-01-31 | $5,579 |
| 2015-10-31 | $5,758 |
| 2015-07-31 | $6,143 |
| 2015-04-30 | $7,145 |
| 2015-01-31 | $3,043 |
| 2014-10-31 | $3,173 |
| 2014-07-31 | $3,134 |
| 2014-04-30 | $4,260 |
| 2014-01-31 | $3,138 |
| 2013-10-31 | $2,988 |
| 2013-07-31 | $2,806 |
| 2013-04-30 | $3,269 |
| 2013-01-31 | $2,809 |
| 2012-10-31 | $2,909 |
| 2012-07-31 | $2,848 |
| 2012-04-30 | $3,082 |
| 2012-01-31 | $2,765 |
| 2011-10-31 | $2,802 |
| 2011-07-31 | $2,787 |
| 2011-04-30 | $2,993 |
| 2011-01-31 | $2,710 |
| 2010-10-31 | $2,814 |
| 2010-07-31 | $2,694 |
| 2010-04-30 | $2,714 |
| 2010-01-31 | $2,584 |
| 2009-10-31 | $2,614 |
| 2009-07-31 | $2,766 |
| 2009-04-30 | $3,169 |
| 2009-01-31 | $2,514 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $118.007B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.924B | 25.68 |
| Boston Scientific (BSX) | United States | $159.425B | 38.08 |
| Stryker (SYK) | United States | $153.031B | 32.00 |
| EssilorLuxottica (ESLOY) | France | $136.054B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.909B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.800B | 25.00 |
| ResMed (RMD) | United States | $40.084B | 30.11 |
| GE HealthCare Technologies (GEHC) | United States | $35.372B | 16.79 |
| Agilent Technologies (A) | United States | $33.937B | 22.12 |
| Terumo (TRUMY) | Japan | $25.318B | 32.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.891B | 17.47 |
| Insulet (PODD) | United States | $20.174B | 79.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.257B | 12.37 |
| Baxter (BAX) | United States | $14.656B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.945B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.996B | 24.34 |
| Lantheus Holdings (LNTH) | United States | $5.072B | 12.79 |
| Perrigo (PRGO) | Ireland | $3.866B | 9.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.792B | 16.94 |
| Haemonetics (HAE) | United States | $3.582B | 16.32 |
| Envista Holdings (NVST) | United States | $3.517B | 29.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| LeMaitre Vascular (LMAT) | United States | $1.856B | 41.49 |
| QuidelOrtho (QDEL) | United States | $1.799B | 12.37 |
| AtriCure (ATRC) | United States | $1.526B | 0.00 |
| Acuren (TIC) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.301B | 13.20 |
| Green Thumb Industries (GTBIF) | United States | $1.217B | 27.38 |
| Phibro Animal Health (PAHC) | United States | $1.208B | 15.44 |
| Neogen (NEOG) | United States | $1.098B | 14.06 |
| BioLife Solutions (BLFS) | United States | $1.074B | 0.00 |
| InMode (INMD) | Israel | $0.944B | 9.51 |
| Kestra Medical Technologies (KMTS) | United States | $0.859B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.741B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.667B | 0.00 |
| Owens & Minor (OMI) | United States | $0.637B | 5.28 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| CeriBell (CBLL) | United States | $0.569B | 0.00 |
| ZimVie (ZIMV) | United States | $0.523B | 23.77 |
| Surmodics (SRDX) | United States | $0.464B | 0.00 |
| SNDL (SNDL) | Canada | $0.420B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.317B | 11.65 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.314B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.312B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.298B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.274B | 81.33 |
| Viemed Healthcare (VMD) | United States | $0.255B | 21.53 |
| OraSure Technologies (OSUR) | United States | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.240B | 0.00 |
| Biote (BTMD) | United States | $0.232B | 6.52 |
| Brainsway (BWAY) | Israel | $0.225B | 59.45 |
| Omeros (OMER) | United States | $0.224B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 15.39 |
| TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.156B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 15.65 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Safety Shot (SHOT) | United States | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 12.98 |
| Quipt Home Medical (QIPT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Agape ATP (ATPC) | $0.074B | 0.00 | |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.21 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |